Patient Note — 253459

4/21/26, 1:34 AM Print Preview [PATIENT_NAME] DOB: [DOB] (81 yo F) Acc No. [ACCOUNT_ID] DOS: 04/10/2026 TV-F/U Patient: [PATIENT_NAME] Provider: [PROVIDER_NAME], MD Account: [ACCOUNT_ID] DOB: [DOB] Age: 81 Y Sex: Female Date: 04/10/2026 Phone: [PHONE] Address: [ADDRESS], ALEXANDRIA, VA-[ZIP] Structured Data: How did you hear about us? : Other Subjective: Chief Complaints: 1. rvw CT. HPI: ARTERA: 81yF is here today for a hospital follow up. S/p L URS/LL with stent (07/03/2025). She was diagnosed with a 3 cm left UPJ and 2 cm left upper pole renal stone. She had left flank pain. She has COPD, HTN, Sleep apnea, MRSA,CVA, anemia and Afib. No longer on Eliquis. She is a resident at The View Alexandria. Unsuccesful Left PCN on 5/8/24.She had proteus bacteremia.She is on chronic doxy for MRSA. Medical History: Screening: Medications: Unknown Acetaminophen , Unknown Albuterol Sulfate HFA , Unknown Atorvastatin Calcium 20 MG Tablet 1 tablet Orally Once a day , Unknown Azelastine HCl 137 MCG/SPRAY Solution Nasal , Unknown Calcium , Unknown Cetirizine HCl , Unknown Culturelle , Unknown Desitin , Unknown Docusate Sodium , Unknown Eliquis(Apixaban) 5 MG Tablet Oral , Unknown Escitalopram Oxalate 10 MG Tablet Oral , Unknown Ferrous Sulfate , Unknown Fluticasone Propionate 50 MCG/ACT Suspension Nasal , Unknown Furosemide 40 MG Tablet Oral , Unknown Loperamide HCl , Unknown Losartan Potassium , Unknown Magnesium , Unknown Omeprazole , Unknown Trelegy Ellipta(Fluticasone-Umeclidin-Vilant) 200-62.5-25 MCG/ACT Aerosol Powder Breath Activated Inhalation , Unknown traZODone HCl , Unknown Vitamin C , Unknown Vitamin D Objective: Vitals: Assessment: Assessment: 1. Left renal stone - N20.0 (Primary) Plan: Treatment: 1. Left renal stone Notes: S/p L URS/LL with stent (07/03/2025). Was recently diagnosed with 3 cm and 2 cm left renal stone. She was recently hospitalized for the same. Unsuccessful left PCN on 05/08/24. She has been doing well since the hospital discharge. Had left flank pain, which got subsided. She denies any major complaints. No urinary issues. Provider: [PROVIDER_NAME], MD Date: 04/10/2026 Generated for Printing/Faxing/eTransmitting on: 04/21/2026 04:34 AM EDT 1/2 4/21/26, 1:34 AM Print Preview [PATIENT_NAME] DOB: [DOB] (81 yo F) Acc No. [ACCOUNT_ID] DOS: 04/10/2026 She is doing well from a urinary standpoint. She is a resident at The View Alexandria. Discussed ureteroscopy with patient. She will be an ideal candidate for this procedure as she had unsuccessful PCN. Risks and benefits discussed in detail. The patient wishes to proceed with ureteroscopy/laser lithotripsy. The patient was informed of potential complications including ureteral perforation (< 5%) and ureteral stricture formation (< 2%). The patient was also educated that a ureteral stent will be placed following the procedure and that potential complications could include irritative voiding symptoms, stent migration, UTI, and encrustation. The procedure will be performed under general anest